Objective: Rheumatoid arthritis (RA) is an autoimmune and inflammatory disease. The prevalence of cardiovascular diseases (CVDs) increases in RA. The CVDs were shown as the primary cause of death in RA. In this study, it was aimed to determine the difference between the patients and the control group by measuring the epicardial adipose tissue (EAT) at the left major coronary artery, which is known as one of the significant risk factors for CVDs in RA patients who underwent computerized tomography (CT) of the thorax due to any reason, through the CT. Method: The study includes 87 patients diagnosed with RA in the remission period and 45 healthy people as the control group. The files and archive records were reviewed and the clinical features of the patient and control groups, the EAT areas in the thorax CT performed, ascending aorta, pulmonary truncus, and pulmonary artery diameters, as well as, the cardiothoracic rates (CTR) measured with CT were recorded. Results: There was no significant difference between the groups in terms of age and gender (p>0.05). It was determined that the EAT measured with CT increased in patients diagnosed with RA compared to the control group and this increase was strictly related to the aortic and pulmonary artery width (p<0.05). In addition, the increase in the EAT area was directly proportional to the CTR in patients diagnosed with RA (p<0.05). It was seen that the ascending aorta diameter, pulmonary truncus diameter, and right and left pulmonary artery diameters increased compared to the control group (p<0.05).
INTRODUCTION
Rheumatoid arthritis (RA) is an autoimmune and inflammatory disease. Its prevalence in different populations varies between 0.4% and 1% 1, 2 . Although it occurs at any age, it is more common between the ages of 35-60. In females, it is seen 2-3 times more than males 3 . RA, which is a chronic multisystemic and inflammatory disease, is associated with significant complications in cardiovascular system 4, 5 . Cardiac involvement in RA may include pericarditis, myocarditis, endocarditis, coronary artery disease, valvular lesions, conduction disturbances, and aortic involvement [5] [6] [7] [8] . The prevalence of cardiovascular diseases (CVDs) increases significantly in the case of RA (4) . CVDs were shown as the major reason for death in RA 6,9 . Epicardial adipose tissue (EAT) is the thoracic visceral adipose tissue that extends between the myocardium and visceral pericardium, and it is seen as a significant cardiovascular risk factor 10, 11 . The fact that EAT is a cardiovascular risk factor arises from the paracrine effects due to the microcirculation that it shares with the myocardium and its closeness to coronary arteries, and local inflammatory effects [12] [13] [14] . In large-scaled community studies conducted, it was accepted that the EAT volume is associated with atherosclerotic lesions and an independent indicator for CVDs 15, 16 .
CT is a more sensitive imaging method compared to echocardiogram (ECHO) in the evaluation of EAT and, with appropriate software, it ensures obtaining independent and objective results of a person [17] [18] [19] [20] . In this study, it was aimed to evaluate the EAT, a significant risk indicator for CVDs, through CT in RA patients and healthy people.
MATERIAL AND METHODS

Study Population:
This retrospective study was conducted with 87 patients diagnosed with RA and 45 healthy people as the control group between April 2012 and September 2014. The RA diagnosis was made in accordance with the ACR and EULAR criteria 21, 22 . The RA group comprises of RA patients with positive rheumatoid factors who do not receive any treatment. The control group, however, included cases with normal laboratory findings who had normal CT results of the thorax recorded in the system.
Inclusion criteria:
Patients aged ≥18 years, who were accepted in the RA remission period (in terms of clinic and laboratory results) and who signed the informed consent forms met the inclusion criteria for the study. The control group, however, included participants who did not have RA or any other inflammatory disease and who had similar demographic information with the RA group such as of age and gender.
Exclusion criteria:
Patients having the features mentioned below were not included in the study: patients with valvular heart disease, chronic obstructive pulmonary disease or any severe systemic disease, occlusive coronary artery disease, coronary failure, chronic liver disease, hypertension, stage 2 or more severe chronic renal failure, those who have DM history, The present study was conducted by using the 128 section multidetector CT device (Aquilion, Toshiba Medical Systems, Tokyo, Japan) and the standard thorax CT protocol of this device. In patients lying in the supine position, the images were obtained with the parameters of KV: 120, rotation time: 0,5, pitch factor: 1,48, helix pitch: 95, FOV: 370, total scanning time: 4,3 sec, and total mAs: 180. Following the tomography, a reconstruction process was performed on the recorded images at a thickness of 5 mm.
The thorax CT images of all persons in the study were received from the image archive system of C.U.M.F. Department of Radiology and the EAT areas in the section at the left major coronary artery outlet were measured through the adipose analysis program (Aquarius iNtuition Edition ver 4.4.6, Tera Recon Inc., San Mateo, CA, ABD) present in the works station (Figure 1) . The ascending aorta, pulmonary truncus right, and left pulmonary artery diameters of the RA and control groups were recorded ( Figure 2 ). In addition, the cardiac thorax indexes (CTR) were measured in patients with RA and were recorded as increased (≥0.5) or standard (<50).
Statistical Analysis:
The SPSS 22.0 (IBM Corporation, Armonk, New York, United States) program was used in the analysis of the variables. In the evaluation of the data, the significance test was used for the difference between two mean values (Kolmogorov-Smirnov) when the parametric test assumptions are fulfilled, and the Chi-square and Mann Whitney U tests were used when the parametric test assumptions are not fulfilled. The ROC analysis was used in the determination of the cut-off point and the p<0.05 value was accepted as statistically significant. 
RESULTS
The study includes 87 RA patients with the mean age of 54.58±11.49 years [15 (%17.2) males, and 72 (%82.8) females] and 45 healthy people with similar age and gender and the mean age of 51.86±11.83 years [11 (24.4%) males, and 34 (75.6%) females]. There was no difference between the groups in terms of age and gender (p>0.05).
While there were significant differences between the RA and control groups in terms of epicardial adipose volume, ascending aorta diameter, pulmonary truncus diameter, and right and left pulmonary artery diameters (p<0.05), there was no significant difference in terms of other measurements (p>0.05) ( Table 1 ). According to the EAT area, the size of the area was found as 0.661 when a cut-off point is searched in the RA group, and the size of this area is statistically significant (p=0.002). Accordingly, the cut-off value for the EAT area in RA patients was found as 16.50 cm², and the sensitivity for this as 52%.
The cut-off value was found as 16.50 cm² for the EAT area in patients diagnosed with RA (AUC:0.661, p<0.05). When the patients were investigated according to the EAT cut-off value, it was determined that 42 patients were under, and 45 patients were above the cut-off value. A statistically significant difference was discovered when the ascending aorta diameters of the patients diagnosed with RA who were divided according to the EAT cut-off value (p<0.05) ( Table 4 ). 
DISCUSSION
Although signs of polyarthritis and inflammation are the most prominent findings in patients with RA, non-negligibly increased CVDs are still the most common cause of death. About 39.6% of patients with RA die because of cardiovascular diseases 23 . In large-scale studies, it was shown that there were increases at the rates of 48% and 50%, respectively, in the major cardiovascular diseases and the cardiovascular disease associated death risk 7,24 .
Okada et al. 25 measured the EAT volume and abdominal visceral adipose tissue area in nonobese patients and found that the EAT volume and CVD were highly correlated. They determined this as a risk factor independently of the body fat accumulation. In the present study, the fact that we found the EAT area high in the RA group is in accordance with the literature for it shows that the RA patients are at risk in terms of CVDs. Giles et al. 26 determined that the increased visceral adipose tissue had a stronger correlation with CVDs compared to some cardiometabolic risk factors when the RA and control groups were compared. In the present study, it was determined that the EAT measured with CT increased compared to patients diagnosed with TA, and this increase was closely associated with the aortic and pulmonary artery width.
However, Oikawa et al. 27 found that the EAT was a more sensitive indicator compared to the abdominal visceral adipose tissue in predicting coronary atherosclerosis. They measured the EAT with CT at the left significant coronary artery level and determined that it was 8.4 (5.1-13.1) cm² in healthy individuals and 11.3 (7.4-16.5) in patients with calcification in the coronary artery. The fact that EAT area was determined to be high in patients with coronary artery plaques shows that EAT was strongly correlated with coronary diseases. Although no plaque was found in any of the individuals included in the present study, the fact that the EAT area of the RA patients was determined as 17.90±10.33 might show that these patients were at high risk in terms of coronary artery disease.
Visceral adipose tissue is an active endocrine and paracrine organ which secretes many proinflammatory and pro-atherogenic cytokines. However, EAT is a unique form of visceral adipose tissue settled under the visceral pericardium. EAT is embryologically similar to intrabdominal visceral adipose tissue. EAT may affect coronary arteries by secreting various bioactive molecules 28, 29 . Many biochemical properties of EAT show that EAT was closely associated with the development of CVDs. In the present study, however, the subcutaneous adipose areas were measured as 248.65±128.97 cm² in the RA group and as 225.68±128.87 cm² in the control group, and there was no significant difference between the groups (p>0.05). When the measurements of the males and females in the RA group were compared, the subcutaneous adipose area and thorax area were found statistically significantly higher in females (p<0.05). It is considered that this difference was because of the fact that the breast adipose tissue entered the cross-sectional area in female patients in the thorax CT section where the adipose analysis was made.
It was shown that the EAT was a stronger and more important risk factor compared to the fatty tissues in other regions of the body in terms of CVD development 30 . The results of the studies performed related to the EAT thickness in previous periods were based on the ECHO findings and the measurements could mostly and only be done on the EAT adjacent to the right ventricle or the pericardial and epicardial adipose tissue [30] [31] [32] [33] . In these studies, it was emphasized that it was hard to make a distinction between the epi-and pericardial adipose tissues 34 . While the EAT could be evaluated through the ECHO and CT, cardiac MR is accepted as the gold standard method in our day 11, 35 . Cardiac MR is a hard and time-consuming method which requires experienced staff for the evaluation. Therefore, it is often used in clinical studies in our day.
However, cardiac CT is an imaging method which provides more objective findings compared to ECHO for the evaluation of the EAT, and it gives results independently of any individual thanks to appropriate software [17] [18] [19] [20] . In the present study, the EAT measurement was evaluated through the thorax CT with proper software. The measures to be carried out by a radiologist in a way to provide practical and objective results were considered as a remarkable and positive situation in our study.
Wallberg -Jonsson et al. 36 reported that the death risk because of cardiovascular reasons in patients with RA increased at the rates of 1.64 in females and 1.47 in males and these rates were significantly higher compared to a healthy population. RA is more frequently seen in females compared to males (2:1) and it peaks in the fifties 2, 3, 37 . In the present study, it was determined that most of the patients diagnosed with RA were females with a mean age of 54.58±11.49 in accordance with the literature (82.8% vs. 17.2%).
Ormseth et al. 12 measured the EAT volume as 108.2 cm 3 (77.0-144.6) in the RA and as 93.9 cm 3 (69.9-133.1) in the control group and showed that there was no statistically significant difference between the two groups. Oyama et al. 38 measured the EAT area at the levels of the right coronary artery, right pulmonary artery, coronary sinus and left major coronary artery and reported that the EAT area at the left major coronary artery level could show the total EAT volume at the best level. In that study, the EAT area at the left major coronary artery level was 4.4 ± 2.0 cm 2 (0.7-11.5), while in the present study, the EAT area in the RA group was significantly higher than the control group (17.90±10.33 cm 2 vs. 11.92±5.24 cm 2 ) (p<0.05). The EAT areas determined in the present study was higher than the studies mentioned. It is considered that the fact that the patients with BMI≥30 kg/m² were excluded from the study by Oyama et al. 38 caused lower results compared to those of the present study.
Kırış et al. 39 measured the EAT thickness in the patient group without the bundle branch block in the heart and determined a strong correlation between the increased EAT thickness and left ventricle dysfunction (LVD) and hypertrophy (LVH). Similarly, Watanabe et al. 40 determined that the increase in the EAT thickness was closely associated with the protected EF LVD. In the present study, it was seen that the CTR increase in RA patients was closely associated with the increased EAT area (p<0.05).
In many recent studies related to the measurements of the aortic arch (AA), it was shown that the AA diameter is an indicator of deaths due to congestive heart failure, stroke, and CVDs. Changes in the extracellular matrix play a key role in the aortic dilatation pathogenesis. EAT may cause dilatation in the ascending aorta with the systemic endocrine effects or local paracrine and passive thermogenic effects on the vascularization. In many of the recent studies conducted on the aortic root measurements, the AA diameter was shown as an important indicator of congestive heart failure, stroke and CVD related deaths [41] [42] [43] . Çanga et al. 44 showed that the increase in the EAT thickness was associated with the increase in the ascending aorta diameter. In the present study, when the cut-off value for the EAT area was determined as 16.50 cm², the AA diameter was measured as 33.09±5.03 mm in the group remaining under and as 36.64±5.49 mm in the group remaining above the cut-off value (p<0.05).
The present study has some limitations. The retrospective nature of the study caused the absence of the chance of simultaneously evaluating the other CVD risk indicators such as carotid intima-media thickness (CIMT), ECHO, and EKG. In addition, the patients could not be assessed in terms of significant cardiovascular outcomes (such as MI, stroke, and death). In addition, the fact that the study was conducted only in Turkish society causes that its results cannot be generalized for other nations. However, the fact that the RA diagnosed patients in this study did not use medical treatment was considered as an essential advantage for the evaluation of EAT in the early period of RA.
As a result, in the present study, it was determined that the EAT evaluated with CT increased in RA patients compared to healthy individuals, and this increase was associated with the aortic and pulmonary artery width. In addition, it was seen that the rise in the EAT area in RA patients was directly proportional to the CTR. The RA patients were significantly at risk for the development of CVDs. It is considered that prospective studies including more patients diagnosed with RA are needed on this subject.
